CDK12 and posterior cortical atrophy: Increasing evidence suggested that the loss of biallelic CDK12 (CDK12-bi), characterized by high genomic instability and tandem duplications, could determine a specific phenotype in PCa with high response to immune checkpoint inhibitors due to the high neoantigen burden (37, 64).